Hormone Replacement Therapy (HRT)

The concern about breast cancer from HRT stems primarily from the 2002 Women's Health Initiative study, which used specific oral synthetic hormones and was subsequently found to have significant methodological limitations. Current evidence — including re-analysis of WHI data and multiple large prospective studies — shows that the absolute risk increase from properly individualized HRT in healthy women is very small, and in many women the benefits significantly outweigh the risks. The decision requires an individualized conversation with a clinically experienced provider — not a blanket yes or no.

Traditional HRT formulations include synthetic hormones chemically distinct from those produced by the human body. Bioidentical hormones are chemically identical to human hormones — the same molecular structure as what your body naturally produces. Bioidentical formulations include FDA-approved products as well as compounded preparations. The key question is not just bioidentical versus synthetic, but individualized dosing and delivery route — both of which significantly affect outcomes and safety profile.

Yes — in several ways. Estrogen therapy helps maintain insulin sensitivity, supports lean muscle mass, reduces visceral fat accumulation, and improves sleep quality — all of which directly counter the metabolic drivers of menopausal weight gain. HRT is not a weight loss medication on its own, but when combined with SPOKEmed's metabolic protocols and nutrition coaching, it removes the hormonal obstacles that make weight management in menopause so difficult.